VANCOUVER, BC / ACCESSWIRE / June 29, 2020 / World-Class Extractions Inc. (CSE:PUMP) (FRA:WCF) (OTCQB:WCEXF) (the "Company" or "World-Class") is pleased to announce the results from its Annual General Meeting of Shareholders held on Friday, June 26, 2020 (the "AGM") in Burnaby, BC.

Shareholders holding a total of 67,713,844 common shares were represented in person or by proxy at the AGM, representing 10.83% of the votes attached to all outstanding common shares of the Company as at the record date. Shareholders voted in favour of all the matters submitted before the AGM as set out in the Notice of Meeting and Information Circular dated May 19, 2020, including:

Setting the size of the Board to five directors and electing the following as directors until the next annual shareholder meeting of the Company: Rosy Mondin, Chand Jagpal, Anthony Durkacz, Donal Carroll and Michael Galloro;
Appointing MNP, LLP, Chartered Professional Accountants, as the Company's auditor for the ensuing year; and
To create a new class of an unlimited number of Class "A", Class "B", Class "C", Class "D", and Class "E" preferred shares issuable in one or more series and amend the Articles of the Company to include any necessary rights and restrictions.

Subsequent to the AGM, the Board re-appointed Mr. Anthony Durkacz as Chairman of the Board and Mr. Donal Carroll, Mr. Chand Jagpal and Mr. Michael Galloro as members of the Audit Committee.

About World-Class Extractions

World- Class is an innovation-driven company with a principle focus on the rapidly evolving cannabis and hemp industries. Through its subsidiaries Soma Labs Scientific Inc. and Greenmantle Products Inc., World-Class deploys and manages custom-built extraction centres utilizing its custom systems, technology, and processes to efficiently produce high-quality cannabis and hemp concentrates and end-products. In addition, through its subsidiary Pineapple Express Delivery Inc. the Company offers compliant and secure delivery of government regulated products, including medical and recreational cannabis in Ontario, Manitoba and Saskatchewan, and liquor delivery in certain jurisdictions in Saskatchewan.

Investor Contact

Daniel Mogil
World-Class Investor Relations
1-604-723-7480
ir@worldclassextractions.com
https://worldclassextractions.com

Neither the Canadian Securities Exchange nor its Regulation Service Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management of the Company.

Cautionary Note Regarding Forward-Looking Statements

All statements in this press release, other than statements of historical fact, are "forward-looking information" with respect to the Company within the meaning of applicable securities laws, the ability of Pineapple Express Delivery to expand its delivery services and to provide discrete shipment of products to Shoppers Drug Mart customers. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited those identified and reported in the Company's public filings under the Company's SEDAR profile at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.

SOURCE: World-Class Extractions Inc.

ReleaseID: 595612

DALLAS, TX / ACCESSWIRE / June 29, 2020 / If you combine passion, intelligence, a natural aptitude for medicine, and a father who was a successful internist, chances are good you would assume Dr. Amir Baluch was a shoo-in for the medical profession. You would think so, but in 2001, he failed to even get into medical school. Distraught and frustrated, he founded an electronic payments business. That failed, too.

At the age of 21, Amir learned one of the most difficult lessons in life – never trust your future to a single source of income. While he was able to resurrect himself, the veritable phoenix from the ashes, that teaching stayed with him, influencing his decisions, his goals, and, ultimately, his path to success.

Today, Dr. Amir Baluch is a successful anesthesiologist. However, he is also a Forbes Councils member, a successful entrepreneur, and a real estate investor. He also works with other doctors to help create 6 and 7-figure eCommerce stores, delivering passive income and peace of mind.

A Foundation for Success

Determined to liberate himself financially, he refused to focus all of his hopes and dreams for success on a medical career. Instead, he invested in himself. After reading hundreds of financial planning books, working with financial advisers, asset managers, and others in the industry, he spent several years learning the ropes in the stock market. That led him to real estate, where he quickly began to make consistent returns over 20%.

Since that point, he hasn't looked back. He expanded his efforts, further shoring up his financial future. Amir obtained his Series 63 and 22 securities licenses and set up Investment Club Realty, LLC, followed by Funding Nest. He also authored the bestselling book, "Make It, Keep It".

Dr. Baluch Offers an Expert Guiding Hand

Today, Dr. Amir Baluch enjoys multiple streams of income. He still practices as an anesthesiologist, helping his patients deal with their pain. However, he has also turned his attention to helping other doctors deal with their pain – the pain of an unsecured financial future. With the creation of his newest company, Global eCommerce Consultants, Dr. Baluch helps doctors build successful Amazon stores that deliver reliable, consistent, passive income.

Dr. Baluch is passionate about exploring new ways to make money and challenging old, antiquated ideas. Amazon offered a unique way to generate passive income while avoiding the risks of outdated ideas and methodologies, but it was Amir's business strategy that truly made the difference. Using software of his own creation, he analyzed metrics to develop a winning formula. He focused on creating Amazon stores selling items that:

Moderate competition with high demand
Not seasonal with sales
Offered a minimum profit of $2
Delivered at least 10% ROI after fees
Sold in a minimum of 30 days

This unique combination allowed him to generate multiple streams of revenue with profitable, high-demand products. He also employs it on behalf of his clients in Global eCommerce Consultants. With each client, he takes a three-pronged approach:

Define the Niche: Finding the right niche is essential, and will include assessing personal experience and conducting extensive research. Dr. Baluch has a dedicated team of six fulltime employees dedicated to nothing but product research and analysis.
Creating Connections and Building Relationships: Successful eCommerce stores require strong relationships based on honesty, respect, following the rules, and being able to connect with managers, salespeople, store employees, and more. This involves meeting suppliers in person, attending conferences, and helping other brands grow.
Exploring and Comparing: It's essential to explore a niche, compare items, and identify products that can deliver at least a 20% profit. Lower-priced competitors, related items that can be cross-sold, and step-up products for upselling are also important elements.

Today, Dr. Amir Baluch puts this strategy and proven philosophy to work on behalf of other doctors. His goal, as always, is to help others build multiple streams of passive income and develop true, lasting success through eCommerce.

For more information, contact:

Amir Baluch
Financial Wellness MD
amir@financialwellnessmd.com

SOURCE: Investment Club Realty, LLC

ReleaseID: 595610

TORONTO, ON and NEW YORK, NY / ACCESSWIRE / June 29, 2020 / Eyecarrot Innovations Corp., (Eyecarrot) (TSX-V:EYC)(OTCQB:EYCCF)(2EYA:GR) a leader is neuro-vision performance technology, announces that its Board of Directors has approved a name change from Eyecarrot Innovations Corp. to Binovi Technologies Corp. In connection with the name change, the Company's trading symbol on the TSX Venture Exchange ("TSXV") will be changed to 'VISN'. It is expected that the name change will be effected on or about June 30, 2020 and the Company's common shares will begin trading under the new name and symbol upon market open on Thursday July 2, 2020, subject to final approval by TSXV. The CUSIP number assigned to the Company's shares following the name change is 09076N109 (ISIN: CA09076N1096). No action is required to be taken by shareholders with respect to the name change. Outstanding share and warrant certificates are not affected by the name change and do not need to be exchanged.

Postponement of Annual Financial Statements

The Company announces the postponement of filing its annual financial statements and management's discussion and analysis (collectively the "Annual Statements") for the year ended February 29, 2020 due to logistics and delays caused by the COVID-19 pandemic.

The Company is relying on exemptive relief granted by Canadian securities regulatory authorities that allows it to delay the filing of its Annual Statements required by sections 4.2 and 5.12(2) of National Instrument 51-102 due to be filed by June 29, 2020. In response to the coronavirus disease pandemic, securities regulatory authorities in Canada have granted a blanket exemption allowing issuers an additional 45 days to complete their regulatory filings.

Eyecarrot anticipates that its Annual Statements will be available for filing at its earliest opportunity, which is expected to occur on or before August 12, 2020. Until such time as the Annual Statements are filed, the Company's management and insiders are subject to a trading blackout that reflects the principals contained in section 9 of National Policy 11-207 – Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions.

Other than as previously disclosed by the Company in news releases, there have been no material business developments since the date of the last interim financial statements filed on January 30, 2020, copies of which are available under the Company's profile on SEDAR at www.sedar.com. The Company will be providing an update news release on the status of filing its February 29, 2020 audited financial statements and its May 30, 2020 first quarter unaudited financial statements by July 29, 2020.

AGORACOM Agreement

The Company announces that further to its news release dated April 28, 2020, it will make its first issuance of shares under its online marketing and awareness program with Agora Internet Relations Corp. ("AGORACOM"). Pursuant to this first tranche, the Company will issue 52,154 common shares of the Company at a deemed price of $0.26. AGORACOM's program includes a "CEO Verified" Discussion Forum. The forum serves as the Company's primary social media platform to interact with both shareholders and the broader investment community in a fully moderated environment.

The Eyecarrot HUB can be found at https://agoracom.com/ir/EyecarrotInnovations.

For additional information on the Company, please visit https://www.eyecarrot.com/investors/.

About Binovi by Eyecarrot

Eyecarrot Innovations Corp. is a human performance technology company that has developed Binovi, a hardware and software-centered platform. Binovi combines hardware, software, specialized expert knowledge, and unique big data insights in order to deliver customized one-on-one training and treatment. Binovi is designed for vision optimization and the enhancement of cognitive skills related to human performance. We are working together under a common banner to help neuro-optometry, vision rehabilitation, and vision performance professionals gain measurable results in less time, and with less effort.

Terry Booth
Executive Chairman

Adam Cegielski
Founder | CEO
Investor Relations
Email: invest@eyecarrot.com
Toll-free: 1 (844) 866-6162
https://www.eyecarrot.com/investors/

Forward looking information

Certain statements contained in this news release constitute "forward-looking information" as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations, and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company's financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company's financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company's continuous disclosure filings filed under the Company's profile at www.sedar.com. The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Eyecarrot Innovations Corp.

ReleaseID: 595608

NEW YORK, NY / ACCESSWIRE / June 29, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Chembio Diagnostics, Inc. ("Chembio" or "the Company") (NASDAQ:CEMI) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Chembio securities between March 12, 2020 and June 16, 2020, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/cemi.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

In April 2020, Chembio's Dual Path Platform ("DPP") COVID-19 antibody test was among the first such tests to be granted Emergency Use Authorization ("EUA") by the U.S. Food and Drug Administration ("FDA"). Then, on June 17, 2020, pre-market, news outlets reported that the FDA had revoked the EUA for Chembio's DPP antibody test, reportedly citing performance concerns with the test's accuracy, a determination that its "benefits no longer outweigh its risks", and "a higher than expected rate of false results." On this news, Chembio's stock price fell $6.04 per share, or 60.83%, to close at $3.89 per share June 17, 2020.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/cemi or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Chembio you have until August 17, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 595487

NEW YORK, NY / ACCESSWIRE / June 29, 2020 / Aegis Capital Corp. acted as Sole Bookrunner on a $5,400,000 Follow-On Offering for Avinger Inc. (NASDAQ:AVGR)

About Avinger Inc.

Avinger is a commercial-stage medical device company that designs and develops the first and only image-guided, catheter-based system for the diagnosis and treatment of patients with Peripheral Artery Disease (PAD). PAD is estimated to affect over 12 million people in the U.S. and over 200 million worldwide. Avinger is dedicated to radically changing the way vascular disease is treated through its Lumivascular platform, which currently consists of the Lightbox imaging console, the Ocelot family of chronic total occlusion (CTO) catheters, and the Pantheris® family of atherectomy devices. Avinger is based in Redwood City, California. For more information, please visit www.avinger.com.

About Aegis Capital Corp.

Aegis Capital Corporation ("Aegis") has been in the wealth management and investment banking business since 1984. Aegis is dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. Aegis also provides research and sales and trading services to institutional investors. Aegis offers its investment representatives a conflict free service platform and is able to provide a full-range of products and services.

For more information about this offering or Investment Banking Services please email InvestmentBanking@aegiscap.com or call (212) 813-1010

www.aegiscapcorp.com

This communication has been prepared by Aegis Capital Corporation for distribution to Aegis Capital Corporation's clientele. This communication is not intended for public dissemination and the recipient is prohibited from sharing this information. This communication has been prepared for institutional – accounts, as defined within FINRA Rule 4512(c), who (1) are capable of evaluating investment risks independently, both in general and with regard to all transactions and investment strategies involving a security or securities; and (2) will exercise independent judgment in evaluating the recommendations of any broker – dealer or its associated persons. This communication is not a product of Aegis Capital Corporation Research Department. Aegis Capital Corporation., Member FINRA, SIPC

SOURCE: Aegis Capital Corp.

ReleaseID: 595611

LOS ANGELES, CA / ACCESSWIRE / June 29, 2020 / Compare-autoinsurance.org (https://compare-autoinsurance.org/) has launched a new blog post that presents some of the most important pieces of information everyone should know about car insurance quotes.

For more info and free car insurance quotes, visit https://compare-autoinsurance.org/car-insurance-quotes-online-explained

Most first-time car owners can feel overwhelmed when shopping for car insurance. Luckily, car insurance quotes can help them outline the types of coverages a policy offers and how much they can expect to pay. Car insurance quotes are estimates, based on the car owner's personal information, of how much a provider will charge on an insurance policy. Because premiums vary across insurers, quotes are very important. To avoid paying too much on an insurance policy, drivers should compare as many quotes as possible. Also, drivers looking to buy a new car should get quotes based on the car they want to get. Furthermore, drivers who are not satisfied by their current provider can also get quotes to find a new carrier that suits their needs.

When determining car insurance premiums, providers use different factors such as:

Age. Older, more experienced drivers cause fewer accidents and are charged less on their insurance rates. Usually, young drivers under 25 pay the highest car insurance premiums.
Gender. Statistically, men are more likely to be involved in an accident. For this reason, car insurance companies charge more on male drivers.
Credit score. In most states, car insurance companies are allowed to use the driver's credit score as a factor to determine the premiums. Statistically, drivers who have a poor credit score are more likely to file car insurance claims. For this reason, they pay more on insurance. On the other hand, drivers with excellent credit score and clean driving records are more likely to receive better deals on their premiums.
Driving record. Policyholders who have a history of at-fault accidents and traffic violations pose a higher financial risk for insurance providers. To lower their risk, insurance companies will charge more on the premiums of drivers with poor driving history.
Address. The place where a driver lives can impact the insurance rates for several reasons. Drivers living in bad neighborhoods where car thefts and vandalism are often will pay more on their insurance. Furthermore, drivers living in a city where there is a high rate of traffic accidents per capita can also expect to be charged more by their carriers.
Make and model of car. Drivers who are driving electric, luxury, sports, or exotic cars will pay more on their insurance because these types of vehicles cost more to repair or to replace. On the other hand, used family cars, minivans, or popular SUV models cost less to insure.
Annual mileage. Drivers who are using their cars to drive frequently are more likely to be involved in accidents and to file insurance claims. To pay less on their premiums, drivers should avoid driving too often.
The type of policy and coverage. Some drivers who own older vehicles choose to purchase only the state minimum insurance required by the law. However, drivers who lease or finance their vehicles are required by their lenders or leasing agents to get full coverage. Furthermore, besides having full coverage, some policyholders add optional coverages to be better covered against different situations.

Drivers looking to get insurance quotes can do so in the office of a local agency of a national insurance carrier, like Allstate, Geico, or State Farm. Drivers can also request quotes via phone or they can get them online. Most major insurers have websites that offer online quotes where drivers will need to give details such as name, address, age, gender, location, vehicle type, how they use the vehicle, and how much they drive, to get quotes. Some insurance providers will even allow drivers to get insurance policies at the end of the quote process.

The insurance policies are sold by agents who work directly with an insurance company or by agents who work independently and can offer multiple quotes from different providers, without having to visit several agencies.

For additional info, money-saving tips and free car insurance quotes, visit https://compare-autoinsurance.org/

Compare-autoinsurance.org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc.

"Car insurance quotes can help drivers find the best insurance policy for them. Insurance providers will determine the cost of a policy after applying several factors..", said Russell Rabichev, Marketing Director of Internet Marketing Company.

CONTACT:

Company Name: Internet Marketing Company
Person for contact: Gurgu C
Phone Number: (818) 359-3898
Email: cgurgu@internetmarketingcompany.biz
Website: https://compare-autoinsurance.org/

SOURCE: Internet Marketing Company

ReleaseID: 595568

Guy Papineau Was Also Appointed A Director Of The Company: Has The Experience & Key Personal Connections In Chilean Mining Industry

HASBROUCK HEIGHTS, NJ / ACCESSWIRE / June 29, 2020 / Kimberly Parry Organics, Corp. ("KPOC" or the "Company") (OTCPINK:KPOC), today announced that, it has appointed a key player in the Chilean mining industry, to be its CEO/President. Guy Papineau, with over 45 years' experience in the industry, will also sit on the Board of Directors of the Company.

Guy brings a vast experience of 45 years in mining, power generation field and environmental processing equipment fields. His experience and skills are in achieving quick and effective results in mining operations. Guy holds a technical degree from (ETS) Ecole de Technologies Superior and also as bachelor's degree in administration from (HEC) University of Montreal. Guy was also involved in several overseas mining projects for Groupe Sainte Genevieve as a senior director overseeing their mining equipment and operations divisions. Groupe Sainte Genevieve operated gold mines in South America, Caribbean and Russia.

Guy also brings the necessary personal and governmental connections and relationships that he developed while being the Company's representative "on-the-ground" in Chile for the last 4 years. He has close ties with the Callejas Family that has been at the forefront of Chilean mining for over 100 years. Mr. Papineau said: "The Callejas Family, which mines copper, gold, lithium and other ores, will be working with KPOC onsite at the Company's first mining operation in its Tilama Project in the Coquimbo region of Chile and its other Chilean mining project sites. Past geological results of the KPOC's Tilama mining territory show significant potential of copper ore, gold, silver and molybdenum resources."

Mr. Papineau continued: "An article titled: "A CENTURY IN MINING" (*) discussed the importance of this association:

"In Chile, as in the rest of the world, family businesses not only play an important role in the country's economic development, but their family members often take key roles in the development and growth of industrial sectors. If we were to single out one Chilean family to have achieved this, it would be the Callejas family, who have been a leading player in the mining business for over a century…" It continued: "(It is) one the most important business families in the Chilean mining area. Former Chilean President, Eduardo Frei Montalva, said: "The history of Chilean mining is written in this family." There is much truth in this statement – the Callejas family isn't just history, it is also the future." (emphasis added)"

Mr. Papineau commented: "My personal collaboration with the "Royalty" of Chilean mining families, brings the Company many benefits that we believe will help accelerate the Company's growth initially and for years to come."

About KCOP Mining, Inc.

The Company's key focus is on acquiring historically productive mining sites and utilizing new technologies to increase higher yields from these proven veins. The Company's first mining operation in its Tilama Project in the Coquimbo region of Chile where in the past the site previously produced excellent results of 4 to 6 % copper oxide per ton, with a production number of 3,500 metric tons per month. The Company intends to bring these production number to 5,000 metric tons in a very short period of three to five months. The Company will also be using the services of cutting edge technologies utilizing aerial drones from Canada, for more accurate geology in prospecting of veins at all their sites, which will help to speed up the future production of other sites at the Tilama mining territory of 3,100 hectares.

KPOC Mining has entered into agreements to purchase 23 copper mining sites in the Republic of Chile. Our geologists have determined that each of mining properties will be highly commercially productive with our new technologies. We believe that development of the first mining site will commence in the second half of 2020, and the remaining sites will be developed over a three- year period. All mining operations will be conducted by KPOC Mining Chile, our Chilean subsidiary.

If you have specific questions about the Company, please email us at admin@kpocmining.com &/or visit our website at www.kpocmining.com .

(*) http://www.campdenfb.com/article/century-mining

Cautionary Language Concerning Forward-Looking Statements:

This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including those with respect to the Company's mission statement and growth strategy, are "forward-looking statements." Although management believes that such forward-looking statements are reasonable, it cannot guarantee that such expectations are, or will be, correct. These forward-looking statements involve a number of risks and uncertainties, which could cause the Company's future results to differ materially from those anticipated. Potential risks and uncertainties include, among others, general economic conditions and conditions affecting the industries in which the Company operates; the uncertainty of regulatory requirements and approvals; and the ability to obtain necessary financing on acceptable terms or at all. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company's filings with the SEC. The Company assumes no obligation to update any of the information contained or referenced in this press release.

Safe Harbor Statement:

CONTACT:
admin@kpocmining.com

SOURCE: tedcol65@gmail.com

ReleaseID: 595605

NEW YORK, NY / ACCESSWIRE / June 29, 2020 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Mylan N.V. ("Mylan" or the "Company") (NASDAQ: MYL) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Mylan securities between February 16, 2016 and May 7, 2019, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/myl.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose rampant abuses of federal quality control regulations, including at Mylan's Morgantown facility. The complaint continues to allege that through a scheme implemented by Mylan's President, Mylan chemists manipulated quality control test data in order to create the facade that Mylan's drugs had achieved passing quality control results. Then, in November 2016, a whistleblower reported Mylan's conduct to the U.S. Food & Drug Administration. Consequently, Mylan was forced to reveal that it would be "restructuring" its Morgantown facility, including by terminating hundreds of employees, and reported a surprise quarterly loss on May 7, 2019. The complaint alleges that when the true details entered the market, investors suffered damages.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/myl or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Mylan you have until August 25, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT: 

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz and Grossman, LLC

ReleaseID: 595609

OTTAWA, ON / ACCESSWIRE / June 29, 2020 / Innovative Medicines Canada released the following statement today in response to the Federal Court of Canada's decision on its judicial review application regarding the Patented Medicine Prices Review Board amendments to the Patented Medicines Regulations:

"We have just received the Federal Court's decision and are reviewing it with our members and with counsel to assess its impact.

"We remain deeply concerned about the negative impact the amended Patented Medicines Regulations will have on Canadians' access to affordable, innovative medicines, and on the country's ability to attract investment to our life-sciences sector.

"The innovative medicines industry has demonstrated its vital role in the health and well-being of Canadians through the COVID-19 crisis, and we must foster a regulatory environment that encourages it to grow and thrive.

"We will closely review the decision with our members to assess its impact on patients and on investment, and determine any next steps."

About Innovative Medicines Canada

Learn more about how our member companies are contributing to the fight against COVID-19.

Innovative Medicines Canada is the national voice of Canada's innovative pharmaceutical industry. We advocate for policies that enable the discovery, development and commercialization of innovative medicines and vaccines that improve the lives of all Canadians. We support our members' commitment to being valued partners in the Canadian healthcare system.

– 30 –

For further information:

Sarah Dion-Marquis
Director, Media and Public Relations
Telephone: 613-769-6510
E-mail: sdmarquis@imc-mnc.ca

SOURCE: Innovative Medicines Canada

ReleaseID: 595606

NEW YORK, NY / ACCESSWIRE / June 29, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Hallmark Financial Services, Inc. ("Hallmark" or "the Company") (NASDAQ:HALL) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Hallmark securities between March 5, 2019 and March 17, 2020, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/hall.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company lacked effective internal controls over accounting and financial reporting related to reserves for unpaid losses; (2) the Company improperly accounted for reserve for unpaid losses and loss adjustment expenses related to its Binding Primary Commercial Auto business; (3) as a result, Hallmark Financial would be forced to report a $63.8 million loss development for prior underwriting years; (4) as a result, Hallmark Financial would exit from its Binding Primary Commercial Auto business; and (5) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/hall or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Hallmark you have until July 6, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 595474